Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Programs Update

Go back to Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Programs Update

Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 5c

March 4, 2016 7:01 AM EST

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

... More